Ultrapure dialysate reduces dose of recombinant human erythropoietin.
Schiffl
H
H
Lang
S M
SM
Bergner
A
A
D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D018592:Cross-Over Studies; D015314:Dialysis Solutions / Q000008:administration & dosage* / Q000592:standards*; D004921:Erythropoietin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000592:standards
D015314:Dialysis Solutions; D011994:Recombinant Proteins; D004921:Erythropoietin